AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2026
Jan 13, 2026
35274_dirs_2026-01-13_7ede639a-4924-49cb-967c-fad956f22368.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2026-01-09
Reporting Person: Williams Donald Allen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-09 | Common Stock | P | 5000 | $1.88 | Acquired | 5728 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3000 | Indirect |
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11